RNS Number : 4151D
McBride PLC
26 June 2019
 

26 June 2019

 

McBride plc

 

Directorate change

 

McBride plc ("McBride" or the "Company") announces the appointment of Jeffrey Nodland as a Non-Executive Director with immediate effect.

 

Jeffrey has extensive experience in consumer chemicals manufacturing businesses including both private label and contract manufacturing activities. He was most recently President and CEO of KIK Custom Products, one of North America's largest independent manufacturers of consumer packaged goods, where between February 2008 and January 2019 he led the turnaround and growth of the business both organically and via acquisition.

 

Previously, Jeffrey held senior positions at speciality chemical businesses including Hexion Speciality Chemicals, Inc., McWhorter Technologies and The Valspar Corporation, with responsibility for activities at a number of speciality chemical plants in western and central Europe, including the UK, Belgium, Italy and Germany.

 

Jeffrey is currently an independent non-executive director of EcoSynthetix, a developer and manufacturer of bio-based polymers for the wood composite and paper industry, which is listed on the Toronto Stock Exchange, and a board member of Augsburg University, Minneapolis. He is a US citizen.

 

Jeffrey will become a member of the Nomination, Remuneration and Audit Committees.

 

John Coleman, Chairman of McBride, said: "We are delighted that Jeff has agreed to join us at McBride. His extensive experience in the household and personal care industry as well as private label and contract manufacturing will bring additional relevant experience to McBride and prove invaluable to the Board in our future discussions."

 

 

McBride has been notified that there are no further details to be disclosed in respect of Jeffrey Nodland pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority

 

 

McBride plc

 

John Coleman, Chairman

0161 203 7570

Rik De Vos, CEO

 

 

 

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1017

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAFKSALANEAF